Company Overview More
CEO: --
Market: NASDAQ
Futu Hot List
USHKCN
TradeSearchNews
SymbolLatest price%Chg

Loading...

SLN Silence Therapeutics
11.000+1.100+11.11%
YOY
Do not show
Hide blank lines
(FY)2021/12/31(Q4)2021/12/31(Q3)2021/09/30(Q2)2021/06/30
Assets
Current assets
Cash, cash equivalents and short term investments
167.9% 73.54M 167.9% 73.54M -- 76.47M 61.37% 81.24M
-Cash and cash equivalents
167.9% 73.54M 167.9% 73.54M -- 71.47M 590.16% 71.24M
-Short-term investments
-- -- -- -- -- 5M -75.01% 10M
Receivables
-- 8.49M -- 8.49M -- -- -- --
-Accounts receivable
-98.87% 331K -98.87% 331K -- 0 -98.67% 438K
-Taxes receivable
93.64% 8.16M 93.64% 8.16M -- 3.78M 13.17% 6.07M
Prepaid assets
-69.09% 4.31M -69.09% 4.31M -- -- -- --
Other current assets
-- -- -- -- -- 2.88M 74.36% 3.6M
Total current assets
13% 86.33M 13% 86.33M -- 83.13M 0.72% 91.35M
Non current assets
Net PPE
72.49% 1.94M 72.49% 1.94M -- 1.54M 57.21% 1.31M
-Gross PPE
20.68% 5.46M 20.68% 5.46M -- -- -- --
-Accumulated depreciation
-3.48% -3.51M -3.48% -3.51M -- -- -- --
Goodwill and other intangible assets
-6.46% 7.62M -6.46% 7.62M -- 7.79M -5.99% 7.77M
-Goodwill
-6.56% 7.59M -6.56% 7.59M -- 7.79M -5.75% 7.76M
-Other intangible assets
41.18% 24K 41.18% 24K -- 3K -75% 7K
Investments and advances
-- 301K -- 301K -- -- -- --
Total non current assets
3.02% 9.86M 3.02% 9.86M -- 9.63M -0.12% 9.38M
Total assets
11.89% 96.19M 11.89% 96.19M -- 92.76M 0.64% 100.73M
Liabilities
Current liabilities
Payables
34.67% 4.57M 34.67% 4.57M -- 9.24M 67.01% 7.87M
-accounts payable
77.9% 4.07M 77.9% 4.07M -- 9.24M 67.01% 7.87M
-Total tax payable
-54.56% 503K -54.56% 503K -- -- -- --
Current accrued expenses
-- 6.22M -- 6.22M -- -- -- --
Current debt and capital lease obligation
-59.82% 137K -59.82% 137K -- 131K 1093.33% 179K
-Current capital lease obligation
-59.82% 137K -59.82% 137K -- 131K 1093.33% 179K
Current deferred liabilities
-- 4.25M -- 4.25M -- -- -- --
Current liabilities
-40.7% 15.17M -40.7% 15.17M -- 18.4M 59.9% 14.76M
Non current liabilities
Non current deferred liabilities
-- 72.5M -- 72.5M -- -- -- --
Total non current liabilities
41.23% 72.5M 41.23% 72.5M -- 58M -1.48% 62.29M
Total liabilities
13.98% 87.67M 13.98% 87.67M -- 76.4M 6.34% 77.06M
Shareholders'equity
Share capital
7.78% 4.49M 7.78% 4.49M -- 4.49M 8.36% 4.49M
-common stock
7.78% 4.49M 7.78% 4.49M -- 4.49M 8.36% 4.49M
Retained earnings
-21.04% -222.97M -21.04% -222.97M -- -213.55M -25.03% -203.68M
Paid-in capital
19.25% 189.53M 19.25% 189.53M -- 189.53M -- 189.51M
Gains losses not affecting retained earnings
-- 23.79M -- 23.79M -- -- -- --
Other equity interest
139.51% 13.69M 139.51% 13.69M -- 11.86M -- 9.34M
Total stockholders'equity
-5.88% 8.53M -5.88% 8.53M -- 16.36M -14.32% 23.67M
Total equity
-5.88% 8.53M -5.88% 8.53M -- 16.36M -14.32% 23.67M
Currency Unit
GBPGBPGBPGBP
Accounting Standards
US-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions
Unqualified Opinion with Explanation------

FY: Financial Year Annual Report, which is equivalent to the 10-K file disclosed by the listed company to the SEC.

Q: Quarterly report, which is equivalent to the 10-Q file disclosed by the listed company to the SEC, where Q1, Q2, Q3, and Q4 are single quarterly reports with a span of 3 months; Q6 and Q9 are cumulative quarterly reports, and Q6 is 6 months , Q9 is 9 months.

The MOM data from the Quarterly report,MOM=(current period - last period)/last period *100%